Sunedison Inc (NYSE:SUNE) is up over 4% in mid-day trading following the company’s announcement that it would extinguish $336 million in debt. In exchange, debt holders will receive a combined 12 million Class A shares of TERP, a yieldco of SunEdison, and interest from renewable assets under development.  According to TipRanks’ statistics, out of the 14 analysts who have rated the company in the last 3 months, 9 gave a Buy rating, 2 gave a Sell rating, and 3 remain on the sidelines. The average 12-month price target for the stock is $13.05, marking a 147% upside from where shares last closed.

SUNE Consensus

Agile Therapeutics Inc (NASDAQ: AGRX) is up 14% in mid-day trading this morning after an initiation from analysts at Noble Financial. The firm initiated a Buy rating today on the company with a price target of $16. According to TipRanks’ statistics, 1 analyst rated the company in the last 3 months with a Buy rating and $18 12-month price target, marking an 80% upside from where shares last closed.

AGRX Consensus

Kura Oncology Inc (NASDAQ:KURA) is up close to 4% in mid-day trading today after analyst Wendy Lam of Oppenheimer initiated a rating on the company. The analyst gave a Buy rating on shares of KURA with a price target of $16.00. According to TipRanks’  statistics, 2 analysts have rated the company in the last 3 months, both with a Buy rating. The average 12-month price target between the two analysts is $17.50, marking a 141% upside from where shares last closed.

KURA Consensus